Chai Discovery | $70,000,000 | (Aug 7, 2025)
Xovian Aerospace | $2,500,000 | (Aug 7, 2025)
Elion | $9,300,000 | (Aug 7, 2025)
Adcentrx Therapeutics
United States
- San Diego, California
- 25/04/2023
- Series A
- $38,000,000
Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. By combining the targeting precision of biologics and the disease fighting power of small molecule payloads, Adcentrx strives to develop next generation targeted therapies for improving patient treatment options.
- Industry Biotechnology Research
- Website https://www.adcentrx.com/
- LinkedIn https://www.linkedin.com/company/adcentrx-therapeutics/
Related People
Hui LiFounder
United States -
San Diego, California
Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. By combining the targeting precision of biologics and the disease fighting power of small molecule payloads, Adcentrx strives to develop next generation targeted therapies for improving patient treatment options.
August | $7,000,000 | (Aug 7, 2025)
Stavtar Solutions | $55,000,000 | (Aug 7, 2025)
Tavily | $25,000,000 | (Aug 7, 2025)
Clay | $100,000,000 | (Aug 7, 2025)
Tracelight | $3,600,000 | (Aug 7, 2025)
CodeKarma | $2,500,000 | (Aug 7, 2025)
WiseBee | $2,444,263 | (Aug 7, 2025)
Positive Development | $51,500,000 | (Aug 7, 2025)
Vendict | $10,000,000 | (Aug 6, 2025)